Navigation Links
NUCRYST Announces Further Adjournment of Special Shareholder Meeting
Date:12/31/2009

NCST; TSX: NCS) following the closing of the sale of the Acticoat business consists primary of cash and short-term investments and no longer has any income other than interest income on its investment balances. The Company retains a few employees who are working towards the completion of the proposed Amalgamation.

This news release contains forward-looking statements within the meaning of securities legislation in the United States and Canada (collectively "forward-looking statements"). Forward-looking statements in this news release include, but are not limited to, statements regarding the completion of the proposed Amalgamation described. With respect to the forward-looking statements contained in this news release, readers are cautioned that numerous risks, uncertainties and other factors could cause actual results or events to differ materially from those indicated in these statements including, but not limited to: the failure to satisfy any of the conditions to closing of the amalgamation agreement; future shareholder actions with respect to the proposed Amalgamation; our ability to satisfy regulatory and stock exchange standards and requirements to complete the proposed Amalgamation; the uncertainty of our future operating results following the completion of the sale of the business. Although we have attempted to identify the important risks, uncertainties and other factors that could cause actual results or events to differ materially from those expressed or implied in the forward-looking statements in this release, there may be other factors that cause actual results or events to differ from those expressed or implied in forward looking statements. For a more thorough discussion of the risks associated with our business, see the "Risk Factors" section in our Annual Report on Form 10-K for the year ended December 31, 2008 and in our Quarterly Reports on Form 10-Q for 2009 as filed with the U.S. Securities and Exchange Commission on EDGAR at '/>"/>

SOURCE NUCRYST Pharmaceuticals Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. NUCRYST Announces the Completion of the Sale of its Acticoat Business
2. NUCRYST Announces Special Meeting of Shareholders
3. NUCRYST Receives Deficiency Notice from NASDAQ
4. European Launch of Acticoat(TM) Flex with NUCRYSTs Nanocrystalline Silver Technology Announced by Smith Nephew
5. Conference Call Advisory - NUCRYST Pharmaceuticals Corp. Conference Call to Discuss 2009 Second Quarter Results
6. NUCRYST announces 2009 first quarter financial results
7. Conference Call Advisory - NUCRYST Pharmaceuticals Corp. Conference Call to Discuss 2009 First Quarter Results
8. NUCRYST Announces Fourth Quarter and Year End 2008 Financial Results
9. NUCRYST Approves $0.80 Per Share Cash Distribution to Shareholders
10. NUCRYST appoints interim CEO
11. NUCRYST Pharmaceuticals appoints a new director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/5/2015)... ... 05, 2015 , ... World Patent Marketing, a vertically integrated ... invention that effectively removes weeds without harming man and nature. , "The Landscaping ... Creative Director of World Patent Marketing. "It is projected to grow at an ...
(Date:7/4/2015)... ... July 04, 2015 , ... Chronic Neck Pain. ... pain sufferers have pain located in the neck. Another 19% suffer from head, migraine, ... Chiropractic literature suggests that 45% of American workers must deal with neck pain. ...
(Date:7/3/2015)... ... July 03, 2015 , ... On June 30th SEO authority ... training system called "Page One Engine" . The program, which has been ... reviews from several well-known marketers. HonestyFirstReviews.com's Tiffany Hendricks has joined the party, publishing ...
(Date:7/3/2015)... ... July 03, 2015 , ... ... healthcare providers, has been retained to lead a national chief nursing officer ... top-ranked executive search firms in the healthcare industry, B. E. Smith has recently ...
(Date:7/3/2015)... ... ... First Choice Emergency Room , the largest network of independent freestanding ... Medical Director of its Frisco facility. , “We are pleased to announce that Dr. ... M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Manzanares ...
Breaking Medicine News(10 mins):Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 2Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 3Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 4Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 5Health News:New Advancement in Treatment of Chronic Neck Pain 2Health News:New Advancement in Treatment of Chronic Neck Pain 3Health News:Page One Engine - Review Of Dori Friend's SEO Training Course Released 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 3
... initiatives should target both coverage and access to health care ... do not have health insurance and no regular source of ... needs, researchers at the University of Michigan C.S. Mott Children,s ... to do more to safeguard the health of vulnerable children, ...
... BCRX ) today announced that its fourth quarter and ... February 6, 2009. Following the release, BioCryst will host a ... to discuss the financial results and provide an update on ... P. Stonehouse, President and Chief Executive Officer, Stuart Grant, Chief ...
... novel Photoconductive Stimulation Device (PSD) was highlighted in the ... Ca2+ Waves Guide CNS Growth Cones to Remote Regions ... 2008 issue of The Public Library of Science One ... mediating axonal guidance. It is known that the path ...
... The assets of Trimlife ( www.trimlife.com ), a ... by The Neutraceutical Company, LLC of Fort Lee, NJ, ... the successful weight-loss product Lipitone ( www.lipitone.com ) and ... well as introduce additional wellness products and services on ...
... (Nasdaq: LCAV ), a leading provider of laser ... announced that it will release fourth quarter and full year ... 10, 2009. A conference call and webcast to discuss ... 2009 at 10:00 a.m. Eastern time.To access the conference call, ...
... Calif., Jan. 30 Patient Safety Technologies (OTC ... closed on $2.55 million of new senior notes ... from the financing will go primarily towards funding ... SurgiCount Medical, the leading provider of tracking ...
Cached Medicine News:Health News:Medical Needs of 6.2 Million U.S. Kids Go Unmet 2Health News:BioCryst Pharmaceuticals to Announce Fourth Quarter and Year End 2008 Financial Results on February 6, 2009 2Health News:BioCryst Pharmaceuticals to Announce Fourth Quarter and Year End 2008 Financial Results on February 6, 2009 3Health News:Novel Photoconductive Cellular Depolarization Technology Reveals Insight Into Neuronal Growth, Guidance, and Regeneration 2Health News:The Neutraceutical Company, LLC Grows Wellness Enhancement Business with Acquisition of North Dakota Based Trimlife.com 2
(Date:7/2/2015)... , June 26, 2015 Research ... "Vitamin D Market by Analog, Application, End-User & by ... to their offering. This market is projected to ... vitamin D in different applications and rising opportunities in countries ... , Italy , and ...
(Date:7/2/2015)... 2, 2015  The Green Exchange, Inc., the developer,s ... HIPAA compliant mobile app that connects cannabis growers directly ... marijuana, announced today that their service provides the fastest ... and more than half a dozen other delivery apps ... Cannabis is unique in that it connects growers ...
(Date:7/2/2015)... , July 2, 2015   Decision ... European retinal specialists identify less frequent dosing as ... (DME), due to the burden on both patients ... endothelial growth factor (VEGF) injections, which are the ... Partners, abicipar pegol, which is in development for ...
Breaking Medicine Technology:Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 2Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 3New Cannabis Delivery App Gets Product to Patient in Under 7 Minutes 2Retinal Specialists Indicate Strong Desire for DME Therapies Which Induce Greater Vision Gains or are Administered Less Frequently Than Currently Approved Anti-VEGF Therapies 2Retinal Specialists Indicate Strong Desire for DME Therapies Which Induce Greater Vision Gains or are Administered Less Frequently Than Currently Approved Anti-VEGF Therapies 3
... 22 Wyeth,Pharmaceuticals, a division of Wyeth (NYSE: ... PGNX ), today announced preliminary results,from two clinical ... RELISTOR(TM) (methylnaltrexone bromide)., The first of these ... of,an oral formulation of RELISTOR for the treatment ...
... Inc. (Nasdaq:,NVAX) today announced that it has created ... against Severe Acute Respiratory Syndrome,(SARS). The company also ... Health (NIH) to continue preclinical development of,SARS vaccine ... now, it has been difficult to produce VLP ...
Cached Medicine Technology:Wyeth and Progenics Announce Preliminary Clinical Trial Results for RELISTOR Oral and Intravenous Formulations 2Wyeth and Progenics Announce Preliminary Clinical Trial Results for RELISTOR Oral and Intravenous Formulations 3Wyeth and Progenics Announce Preliminary Clinical Trial Results for RELISTOR Oral and Intravenous Formulations 4Wyeth and Progenics Announce Preliminary Clinical Trial Results for RELISTOR Oral and Intravenous Formulations 5Wyeth and Progenics Announce Preliminary Clinical Trial Results for RELISTOR Oral and Intravenous Formulations 6Wyeth and Progenics Announce Preliminary Clinical Trial Results for RELISTOR Oral and Intravenous Formulations 7Novavax Announces Proprietary Method to Create SARS Vaccine and Renewal of NIH Funding for SARS Vaccine Development 2Novavax Announces Proprietary Method to Create SARS Vaccine and Renewal of NIH Funding for SARS Vaccine Development 3
... playful, the Thalia Girls ... girls who love fashion ... accents and sparkling rhinestones ... exciting collection.Thalia Girls collection ...
... whimsy, charm and cutting edge fashion that ... inspired by Cynthia Rowley's creativity, wit and ... Kenmark Group and B Robinson collaborating with ... optical and four sunwear designs with additional ...
... that almost all retailers must address these ... VALUE - not just in price but ... shows that National is among the LEADING ... offers an exciting collection of contemporary and ...
... Esprit is an internationally known brand ... image. The ophthalmic collection offers chic ... and creativity in titanium, metal and ... features unique styling with trendy shapes ...
Medicine Products: